Implantable Port Archives - Page 3 Of 6

Implantable port catheter tip location and complication rates

“The position of the catheter tip of totally implantable venous access devices (TIVAD) is a risk factor for postoperative complications. The study aim was to assess the early and late complications (EC and LC) associated with the position of the catheter tip in cancer patients” Hamri et al (2024).

Implantable port care standards

“This study aimed to determine the practices of nurses working in pediatric and adult oncology clinics regarding totally implantable venous access device (TIVAD) care” Gündogdu et al (2024).

Unplanned early implantable port removal – Full Text

“This study aims to determine the risk factors associated with unplanned (catheter removal other than completion of treatment plan) early (within 90 days of catheter implantation) implantable port catheter removal” Lu et al (2024).

Management of implantable port complications – Full Text

“Totally implanted venous access devices (TIVAD)/chemoports are indispensable in the management of cancer patients, especially in patients requiring long duration of infusion and prolonged treatment. Although chemoports are associated with a spectrum of complications, proper technique of implantation and use makes it a safe and reliable tool” Sharma and Pandey (2024).

FICC-ports – novel femoral implantable port

“In the last 3 years, we have implanted 47 FICC-ports in young adults with mediastinal lymphoma compressing the superior vena cava. We had no immediate/early complication, and only three late complications” Annetta et al (2024).

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Totally implantable ports in infants and children – Full Text

“The type of port, including the material of the port’s venous catheter, and the underlying disease have an impact on the durability of implantable intravenous systems” Sosnowska-Sienkiewicz et al (2024).

Basilic vein variation during arm port placement – Full Text

“Basilic vein variation usually presents without any clinical symptoms and is often regarded as a benign alteration. This case was a patient with congenital basilic vein variation encountered during surgery for an infusion port” Hu et al (2024).

Implantable port insertion pocket-first technique – Full Text

“The pocket-first technique can be considered as a safe, feasible and convenient technique for TIVAP implantation. The time consuming is significantly shortened compared with the puncture-first technique and this advantage may be more obvious when using SCV/AxV approach” Wu et al (2024).

Patient experience with implanted venous access ports – Full Text

“The participants highlighted both the positive and negative aspects of venous access ports, while also identifying insufficient knowledge and “fear and anxiety” as barriers to accepting these devices” Janatolmakan et al (2024).

Ultrasound guided implantation of venous access ports – Full Text

“The aim of this study was to present demographic information of patients undergoing totally implantable venous access port (TIVAP) implantation and to investigate the rates of early and late complications, assessing the benefits of performing the procedure under US guidance” İlhan et al (2024).

Scarless totally implantable access port implantation – Full Text

“The scarless TIVAP implantation is a safe & reliable procedure with high patients-reported aesthetic satisfaction, and could be an alternative TIVAP procedure for patients requiring chemotherapy and desiring a less noticeable scar” Chang et al (2024).

Implantation of venous access port tip – Full Text

“To assess the safety and feasibility of intentionally positioning the catheter tip in the right atrium (RA) without an abutment during implantation of a totally implantable venous access port (TIVAP)” Park et al (2024).

Central venous ports for IV chemotherapy in infants – Full Text

“However, the feasibility and safety of the CVP for IVC in infants remain unknown. This study evaluated the usefulness of CVP for IVC in infants with retinoblastoma” Kubo et al (2024).

Radiation exposure during venous access port implantation

“pgrading the fluoroscopy equipment and completing two dedicated training courses allowed for a drastic decrease patient exposure to ionizing radiation during venous access port implantation by non-radiologist practitioners” Vallot et al (2024).

Implantable port infection risk

“In many patients with port infection, the ports are removed because antibiotics are ineffective. We evaluated the risk factors associated with port removal due to port infection” Hara et al (2024).

Implantable port infection and complication rates

“Double-lumen chest ports are associated with increased risk for bloodstream infection, malfunction, fibrin sheath formation, catheter tip malposition, and catheter-associated thrombosis” Kozlowski et al (2024).

Implantable port pocket infection risk

“Skin complications after the central venous port placement were related to cetuximab administration and the timing of cetuximab therapy” Sueyoshi et al (2024).

Implantable port or peripheral IV for CT contrast

“To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-material injection for contrast enhancement during the portal venous phase” Washio et al (2024).

Implantable port CLABSI study – Full Text

“PORT implantation should be avoided in patients who had antibiotic treatment episodes within 1 week, especially for those with low serum TP levels” Chen et al (2023).

Implantable port position satisfaction survey – Full Text

“The port position should be chosen together with patients/caregivers based on the (dis-)advantages of each position, as identified by this study” van den Bosch et al (2024).

Improving knowledge and skills of implantable port patients

“The main objective of the study was to assess the impact of a pharmaceutical interview on patients’ knowledge and skills for patients with TIVAP” Nizet et al (2023).

PICC-port education for ultrasound-based tip location

“To create an educational program and provide a valid, evidence-based course for ultrasound-based tip location during placement of PICC-port for specialized nurses” Shen et al (2023).

Clinical outcomes of ultrasound-guided totally implantable venous access ports

“Ultrasound-guided TIVAP implantation via the posterior approach of the IJV is feasible, safe, and effective, with a low rate of intraoperative and postoperative complications” Wang et al (2023).

Implantable port catheter misplaced into the right subclavian artery – Full Text

“Radiologic identification of an arterially placed catheter is crucial not only because of the risks associated with using the port system but also due to the potential for severe hemorrhage during catheter removal. For these patients, a vascular occluder can be employed to seal the puncture site, preventing significant trauma that could result from open surgery” Chen et al (2023).

Implantable port fragment in the heart – Full Text

“Patient presented with problems with regards to her mediport including difficulties in flushing during the administration of chemotherapeutic agents. Chest X-ray was notable for broken/dislodged mediport catheter in the right heart” Yarrarapu and Panchal (2023).

Category: Implantable Port